MedPath

The Effect Of Munditika Choornam In The Management Of Vatarakta (RA)

Not Applicable
Conditions
Health Condition 1: M04-M04- Autoinflammatory syndromes
Registration Number
CTRI/2023/06/054074
Lead Sponsor
Kizhakkemadathil Nimisha K V Narendran
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Males and females patients of age group 30-60 years, diagnosed with Vatarakta as per the prevalidated tool and Rheumatoid arthritis by satisfying 2010 ACR criteria.

Exclusion Criteria

I.Patients diagnosed with Vatarakta as per the prevalidated tool based on the lakshanas but also diagnosed with Systemic Lupus Erythematous, Sjogrenâ??s disease, gout.

II.Patients with major structural deformity as a complication of Rheumatoid Arthritis.

III.Patients with known history of major liver disorders, lung disorders and cardiac illness.

IV.Pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in DAS 28 scale <br/ ><br>Changes in prevalidated tool based on the lakshana of Vata rakta <br/ ><br>Changes in grading of tenderness, morning stiffness <br/ ><br>Changes in lab investigations for estimation of ESR, LFT, RFT, RA factor, Anti CCP, CRP <br/ ><br> <br/ ><br>Timepoint: 0th & 31st day
Secondary Outcome Measures
NameTimeMethod
Changes in prevalidated tool based on the lakshana of Vata rakta <br/ ><br>Changes in grading of tenderness, morning stiffnessTimepoint: 0th & 31st day
© Copyright 2025. All Rights Reserved by MedPath